Kintegral Advisory LLC Has $1.08 Million Holdings in Colgate-Palmolive Company (NYSE:CL)

Kintegral Advisory LLC cut its stake in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 32.9% during the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 11,543 shares of the company's stock after selling 5,660 shares during the period. Kintegral Advisory LLC's holdings in Colgate-Palmolive were worth $1,082,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the stock. Aviva PLC lifted its stake in Colgate-Palmolive by 13.4% in the fourth quarter. Aviva PLC now owns 973,421 shares of the company's stock valued at $88,494,000 after acquiring an additional 114,855 shares during the last quarter. Autumn Glory Partners LLC raised its holdings in shares of Colgate-Palmolive by 67.4% during the 1st quarter. Autumn Glory Partners LLC now owns 8,905 shares of the company's stock valued at $851,000 after purchasing an additional 3,586 shares in the last quarter. Jupiter Asset Management Ltd. lifted its stake in shares of Colgate-Palmolive by 2.3% in the 4th quarter. Jupiter Asset Management Ltd. now owns 685,718 shares of the company's stock valued at $62,339,000 after purchasing an additional 15,142 shares during the last quarter. Summit Investment Advisors Inc. boosted its holdings in Colgate-Palmolive by 10.8% in the fourth quarter. Summit Investment Advisors Inc. now owns 32,710 shares of the company's stock worth $2,974,000 after purchasing an additional 3,187 shares in the last quarter. Finally, Capula Management Ltd acquired a new position in Colgate-Palmolive during the fourth quarter worth $374,000. Institutional investors and hedge funds own 80.41% of the company's stock.

Colgate-Palmolive Stock Performance

NYSE CL traded down $1.15 on Tuesday, reaching $92.18. The stock had a trading volume of 6,099,806 shares, compared to its average volume of 4,829,382. Colgate-Palmolive Company has a 1-year low of $85.32 and a 1-year high of $109.30. The company has a debt-to-equity ratio of 8.96, a current ratio of 0.85 and a quick ratio of 0.54. The company has a market cap of $74.70 billion, a P/E ratio of 26.04, a price-to-earnings-growth ratio of 4.96 and a beta of 0.37. The firm has a fifty day moving average of $90.66 and a two-hundred day moving average of $90.54.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings results on Friday, April 25th. The company reported $0.91 EPS for the quarter, topping analysts' consensus estimates of $0.86 by $0.05. The company had revenue of $4.91 billion for the quarter, compared to analysts' expectations of $4.92 billion. Colgate-Palmolive had a return on equity of 461.04% and a net margin of 14.52%. Colgate-Palmolive's revenue was down 3.0% on a year-over-year basis. During the same quarter last year, the business earned $0.86 earnings per share. On average, equities research analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive declared that its Board of Directors has initiated a stock buyback program on Thursday, March 20th that authorizes the company to buyback $5.00 billion in outstanding shares. This buyback authorization authorizes the company to purchase up to 6.8% of its shares through open market purchases. Shares buyback programs are typically an indication that the company's leadership believes its shares are undervalued.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, August 15th. Stockholders of record on Friday, July 18th will be issued a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 2.26%. The ex-dividend date is Friday, July 18th. Colgate-Palmolive's dividend payout ratio (DPR) is currently 58.76%.

Wall Street Analyst Weigh In

CL has been the subject of a number of analyst reports. Citigroup boosted their price target on Colgate-Palmolive from $103.00 to $108.00 and gave the stock a "buy" rating in a research report on Monday, April 28th. Piper Sandler decreased their target price on Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating for the company in a research report on Monday, March 31st. Wall Street Zen downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating in a report on Wednesday, May 7th. JPMorgan Chase & Co. boosted their price objective on shares of Colgate-Palmolive from $95.00 to $103.00 and gave the stock an "overweight" rating in a research note on Monday, April 28th. Finally, Wells Fargo & Company upped their price objective on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the stock an "underweight" rating in a report on Wednesday, April 2nd. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and nine have given a buy rating to the stock. According to MarketBeat, Colgate-Palmolive currently has an average rating of "Hold" and an average target price of $101.69.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.